Sage Therapeutics (SAGE)
(Real Time Quote from BATS)
$14.66 USD
+0.97 (7.09%)
Updated Apr 29, 2024 01:04 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Sage Therapeutics, Inc. [SAGE]
Reports for Purchase
Showing records 81 - 100 ( 152 total )
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Just The Beginning - SAGE-324 KINETIC Data Signals Advancement
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Notes From The (Virtual) Road... Management Meetings Move Through The LANDSCAPE
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
More Positive Data from SHORELINE Bolsters Confidence in Zuranolone as WATERFALL Readout Nears
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
2021 Poised as a Year of Readouts in Uneventful 4Q Call; Reiterate Buy, PT to $86
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
With WATERFALL Enrollment Complete, Much To Look Forward To In 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
CEO Transition Announced - Barry Greene To Assume Role
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Cyber Monday Conference Call Doesnt Address All the Questions from Black Friday Deal; Reit. Neutral, Lower PT to $74
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Unexpected Black Friday Deal Raises Questions; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Biotechnology - SAGE, BIIB Enter Collaboration Deal
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Relatively Quiet Quarter of Execution as Key Zuranolone Readout Approach in 2021; Reiterate Neutral, PT up to $81
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
We See 2021 As A Critical Year; All Efforts On Track
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L